DE10312809A1 - Pramipexol zur Reduzierung übermäßiger Nahrungsaufnahme bei Kindern - Google Patents

Pramipexol zur Reduzierung übermäßiger Nahrungsaufnahme bei Kindern Download PDF

Info

Publication number
DE10312809A1
DE10312809A1 DE10312809A DE10312809A DE10312809A1 DE 10312809 A1 DE10312809 A1 DE 10312809A1 DE 10312809 A DE10312809 A DE 10312809A DE 10312809 A DE10312809 A DE 10312809A DE 10312809 A1 DE10312809 A1 DE 10312809A1
Authority
DE
Germany
Prior art keywords
pramipexole
children
optionally
use according
food intake
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE10312809A
Other languages
German (de)
English (en)
Inventor
Joachim Mierau
Jürgen REESS
Marion Wienrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma GmbH and Co KG filed Critical Boehringer Ingelheim Pharma GmbH and Co KG
Priority to DE10312809A priority Critical patent/DE10312809A1/de
Priority to US10/801,286 priority patent/US20040266794A1/en
Priority to EP04721477A priority patent/EP1608367A1/fr
Priority to CA002519584A priority patent/CA2519584A1/fr
Priority to JP2006504716A priority patent/JP2006520764A/ja
Priority to PCT/EP2004/002793 priority patent/WO2004082680A1/fr
Publication of DE10312809A1 publication Critical patent/DE10312809A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE10312809A 2003-03-21 2003-03-21 Pramipexol zur Reduzierung übermäßiger Nahrungsaufnahme bei Kindern Withdrawn DE10312809A1 (de)

Priority Applications (6)

Application Number Priority Date Filing Date Title
DE10312809A DE10312809A1 (de) 2003-03-21 2003-03-21 Pramipexol zur Reduzierung übermäßiger Nahrungsaufnahme bei Kindern
US10/801,286 US20040266794A1 (en) 2003-03-21 2004-03-16 Pramipexole for the reduction of excessive food intake for children
EP04721477A EP1608367A1 (fr) 2003-03-21 2004-03-18 Utilisation de pramipexol pour reduire l'absorption excessive d'aliments chez les enfants
CA002519584A CA2519584A1 (fr) 2003-03-21 2004-03-18 Utilisation de pramipexol pour reduire l'absorption excessive d'aliments chez les enfants
JP2006504716A JP2006520764A (ja) 2003-03-21 2004-03-18 子供による過剰な食物摂取を低減するためのプラミペキソール
PCT/EP2004/002793 WO2004082680A1 (fr) 2003-03-21 2004-03-18 Utilisation de pramipexol pour reduire l'absorption excessive d'aliments chez les enfants

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10312809A DE10312809A1 (de) 2003-03-21 2003-03-21 Pramipexol zur Reduzierung übermäßiger Nahrungsaufnahme bei Kindern

Publications (1)

Publication Number Publication Date
DE10312809A1 true DE10312809A1 (de) 2004-09-30

Family

ID=32921094

Family Applications (1)

Application Number Title Priority Date Filing Date
DE10312809A Withdrawn DE10312809A1 (de) 2003-03-21 2003-03-21 Pramipexol zur Reduzierung übermäßiger Nahrungsaufnahme bei Kindern

Country Status (5)

Country Link
EP (1) EP1608367A1 (fr)
JP (1) JP2006520764A (fr)
CA (1) CA2519584A1 (fr)
DE (1) DE10312809A1 (fr)
WO (1) WO2004082680A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100168191A1 (en) * 2007-05-25 2010-07-01 Boehringer Ingelheim International Gmbh Pharmaceutical formulation comprising pramipexole
EP4245765A3 (fr) 2013-04-04 2024-03-20 Boehringer Ingelheim Vetmedica GmbH Traitement de troubles metaboliques chez des animaux equins
DK3082829T3 (da) 2013-12-17 2021-05-03 Boehringer Ingelheim Vetmedica Gmbh Sglt2-inhibitorer til behandlingen af metaboliske lidelser i kattedyr
LT3485890T (lt) 2014-01-23 2023-07-25 Boehringer Ingelheim Vetmedica Gmbh Sglt2 inhibitoriai, skirti šuninių gyvūnų medžiagų apykaitos sutrikimų gydymui
MX2016012705A (es) 2014-04-01 2016-12-16 Boehringer Ingelheim Vetmedica Gmbh Tratamiento de trastornos metabolicos en animales equinos.
EP3197429B1 (fr) * 2014-09-25 2024-05-22 Boehringer Ingelheim Vetmedica GmbH Polythérapie avec des inhibiteurs de sglt2 et des agonistes de la dopamine utilisée pour la prévention des troubles métaboliques chez des équidés
AU2016310535B2 (en) 2015-08-27 2021-08-19 Boehringer Ingelheim Vetmedica Gmbh Liquid pharmaceutical compositions comprising SGLT-2 inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8800823A (nl) * 1987-04-10 1988-11-01 Sandoz Ag Werkwijze voor het toepassen van dopamine-receptor agonisten en farmaceutische preparaten die deze agonisten bevatten.
US20010016582A1 (en) * 1997-04-28 2001-08-23 Anthony H. Cincotta Method and composition for the treatment of lipid and glucose metabolism disorders
AU2080201A (en) * 1999-12-10 2001-06-18 University Of Cincinnati, The Treatment of addiction disorders
DE10148233A1 (de) * 2001-09-28 2003-04-10 Boehringer Ingelheim Pharma Verbindungen zur Reduzierung übermäßiger Nahrungsaufnahme
US20040077679A1 (en) * 2002-07-29 2004-04-22 Cincotta Anthony H. Therapeutic treatment for the metabolic syndrome and type 2 diabetes

Also Published As

Publication number Publication date
JP2006520764A (ja) 2006-09-14
CA2519584A1 (fr) 2004-09-30
EP1608367A1 (fr) 2005-12-28
WO2004082680A1 (fr) 2004-09-30

Similar Documents

Publication Publication Date Title
US20080051443A1 (en) Compounds for the reduction of excessive food intake
DE60119896T2 (de) Verwendung von pramipexol zur behandlung von tabak/nikotin abhängigkeit
DE3235093A1 (de) Antiparkinsonmittel
EA015382B1 (ru) Применение рофлумиласта для лечения сахарного диабета типа 2
DE60111025T2 (de) Verwendung von Topiramat zur Behandlung und Diagnostizierung von Atemstörungen während des Schlafens und Mittel zur Durchführung der Behandlung und Diagnose
US20230052152A1 (en) Compounds for treatment of alzheimer's disease
EP1397138A2 (fr) Association de principes actifs destinee au traitement medicamenteux d'une intoxication a des substances entrainant une dependance ou a des stupefiants
JP6499634B2 (ja) 過活動膀胱の治療のためのソリフェナシンと唾液分泌刺激剤の組合せ
DE10312809A1 (de) Pramipexol zur Reduzierung übermäßiger Nahrungsaufnahme bei Kindern
DE69529819T2 (de) Neue kombination eines betablockers mit einem lokalanästhetikum
DE112013002717T5 (de) Induktion von Arteriogenese mit einem NO (Stickstoffmonoxid)-Donor
DE10163667B4 (de) Verwendung von Desoxypeganin zur Behandlung der klinischen Depression
EP1418908B1 (fr) Composes permettant de supprimer et/ou de soulager l'anhedonie
DE2611976A1 (de) Pharmazeutisches praeparat zur besserung und wiederherstellung bei verminderten bewusstseinszustaenden
DE2743704C2 (de) L- oder DL-Phenylglycine enthaltende Arzneimittel
US20040266794A1 (en) Pramipexole for the reduction of excessive food intake for children
DE2820808A1 (de) Arzneimittel mit einer antanginoesen wirksamkeit
DE3804858A1 (de) Mittel gegen hyperurikaemie
EP0479874A1 (fr) Utilisation de nor-verapamil et de nor-gallopamil en tant qu'agents anti-arteriosclereux.
DE2823267A1 (de) Antihypertensive praeparate
EP1416930A1 (fr) Pramipexol destine au traitement de le thada
Gul et al. ACUTE ANAPHYLAXIS WITH LIGNOCAINE: Acute Anaphylaxis
AT507103A2 (de) Mittel zur unterstützung bei liebeskummer und trennungsschmerz
DE102011108116A1 (de) Reserpin zur Behandlung von kognitiven Störungen des zentralen Nervensystems
DE2128730B (de) Mittel zur Kompensierung eines Do paminmangels im Gehirngewebe

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee